This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) rose 5.28% to $7.18 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.19% to 4,307.54 and Dow Jones Industrial Average falling 1.59% to 33,843.92. The stock's rise snapped a two-day losing streak. Ocugen Inc. closed $11.59 short of its 52-week high ($18.77), which the company reached on February 8th.
The stock outperformed some of its competitors Thursday, as Adverum Biotechnologies Inc. (ADVM) fell 1.36% to $2.17, Ocular Therapeutix Inc. (OCUL) fell 1.38% to $10.00, and Kodiak Sciences Inc. (KOD) fell 1.58% to $95.98. Trading volume (6.8 M) remained 5.3 million below its 50-day average volume of 12.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2021.
(END) Dow Jones Newswires
September 30, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.